keyword
https://read.qxmd.com/read/38656630/safety-and-efficacy-of-multiple-dose-versus-single-dose-mibg-therapy-in-patients-with-refractory-pheochromocytoma-and-paraganglioma-a-single-center-retrospective-analysis
#1
JOURNAL ARTICLE
Naoto Wakabayashi, Shiro Watanabe, Takashige Abe, Junki Takenaka, Kenji Hirata, Rina Kimura, Keita Sakamoto, Nobuo Shinohara, Kohsuke Kudo
OBJECTIVE: To investigate the incidence of adverse events (AEs) following single and multiple administrations of I-131 metaiodobenzylguanidine (MIBG) therapy for inoperable pheochromocytomas and paragangliomas (PPGLs). METHODS: A single-center retrospective study was conducted on patients with inoperable PPGLs who underwent I-131 MIBG therapy between January 2000 and December 2020. A total of 28 patients with available electronic medical records were included. The treatment consisted of a single intravenous administration of 150 mCi (5...
April 24, 2024: Annals of Nuclear Medicine
https://read.qxmd.com/read/38656586/chagas-cardiomyopathy-and-myocardial-sympathetic-denervation
#2
REVIEW
Leonardo Pippa Gadioli, André Schmidt, Benedito Carlos Maciel, Gustavo Jardim Volpe, Marcus Vinicius Simões, José Antonio Marin-Neto
PURPOSE OF REVIEW: More than a century since its discovery, the pathogenesis of Chagas heart disease (CHD) remains incompletely understood. The role of derangements in the autonomic control of the heart in triggering malignant arrhythmia before the appearance of contractile ventricular impairment was reviewed. RECENT FINDINGS: Although previous investigations had demonstrated the anatomical and functional consequences of parasympathetic dysautonomia upon the heart rate control, only recently, coronary microvascular disturbances and sympathetic denervation at the ventricular level have been reported in patients and experimental models of CHD, exploring with nuclear medicine methods their impact on the progression of myocardial dysfunction and cardiac arrhythmias...
April 24, 2024: Current Cardiology Reports
https://read.qxmd.com/read/38652045/approach-to-the-patient-concept-and-application-of-targeted-radiotherapy-in-the-paraganglioma-patient
#3
JOURNAL ARTICLE
Karel Pacak, David Taieb, Frank I Lin, Abhishek Jha
Paragangliomas can metastasize, posing potential challenges in both symptomatic management and disease control. Systemic targeted radiotherapies using 131I-MIBG and 177Lu-DOTATATE are a mainstay in the treatment of metastatic paragangliomas. This clinical scenario and discussion aim to enhance physicians' knowledge of the stepwise approach to treat these patients with paraganglioma targeted radiotherapies. It comprehensively discusses current approaches to selecting paraganglioma patients for targeted radiotherapies and how to choose between the two radiotherapies based on specific patient and tumor characteristics, when either therapy is feasible, or one is superior to another one...
April 23, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38650712/anlotinib-for-metastatic-progressed-pheochromocytoma-and-paraganglioma-a-retrospective-study-of-real-world-data
#4
JOURNAL ARTICLE
Rui Tian, Xiaochen Yao, Jieping Song, Jun Wang, Jingjing Fu, Liang Shi, Fei Yu, Pengjun Zhang, Chuan Zhang, Yudan Ni, Feng Wang
INTRODUCTION: Pheochromocytomas (PCC) and paragangliomas (PGL) (collectively PPGL) are a type of rare hypervascular neuroendocrine tumors that are very challenging to treat. This study aimed to determine the efficacy and safety of the multi-tyrosine kinase inhibitor anlotinib for the treatment of locally advanced or metastatic (LA/M) PPGL. METHODS: A total of 37 eligible patients with unresectable or progressive LA/M PPGL were enrolled. Of them, 27 patients received anlotinib alone (n = 19) or in combination (n = 8) with radionuclide therapies, including peptide receptor radionuclide therapy (PRRT) and iodine 131 meta-iodobenzylguanidine (131 I-MIBG)...
April 6, 2024: Journal of the Endocrine Society
https://read.qxmd.com/read/38630996/high-specific-activity-131i-mibg-for-the-treatment-of-advanced-pheochromocytoma-and-paraganglioma
#5
JOURNAL ARTICLE
Ruaa Al-Ward, Vania Balderrama Brondani, Sahar Sawani, Cheryl L Potter, Guofan Xu, Steven G Waguespack, Jeena Varghese, Mouhammed Amir Habra, Yang Lu, Camilo Jimenez
PATIENTS AND METHODS: The primary endpoints were objective response rate (ORR) and disease control rate (DCR). Secondary endpoints were duration of response, blood pressure control, safety, overall and progression-free survival rates, MIBG uptake, and correlations with genetic background. RESULTS: The study included 25 patients. Twenty-four patients had distant metastases, 17 (68%) had hormonally active tumors, and 13 (52%) had previously received antineoplastic treatment...
April 17, 2024: Clinical Nuclear Medicine
https://read.qxmd.com/read/38626389/feasibility-study-of-single-photon-emission-computed-tomography-with-iodine-123-labeled-metaiodobenzylguanidine-for-preclinical-evaluation-of-labetalol-as-a-%C3%AE-adrenergic-receptor-blocker
#6
JOURNAL ARTICLE
Yiseul Choi, Eun Sang Lee, Sang-Keun Woo, Kyo Chul Lee, Hye Kyung Chung, Joo Hyun Kang
Among clinically used radiopharmaceuticals, iodine-123 labeled metaiodobenzylguanidine ([123 I]mIBG) serves for diagnosing neuroendocrine tumors and obtaining images of myocardial sympathetic innervation. mIBG, a structural analogue of norepinephrine (NE), a neurotransmitter acting in peripheral and central nerves, follows a pathway similar to NE, transmitting signals through the NE transporter (NET) located at synaptic terminals. It moves through the body without decomposing, enabling noninvasive image evaluation...
April 16, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38617812/3-18-f-fluoro-para-hydroxyphenethylguanidine-3-18-f-phpg-pet-a-novel-imaging-modality-for-paraganglioma
#7
JOURNAL ARTICLE
Tobias Else, Ka Kit Wong, Kirk A Frey, Allen F Brooks, Benjamin L Viglianti, David M Raffel
CONTEXT: Functional positron emission tomography (PET) imaging for the characterization of pheochromocytoma and paraganglioma (PCC/PGL) and for detection of metastases in malignant disease, offers valuable clinical insights that can significantly guide patient treatment. OBJECTIVE: This work aimed to evaluate a novel PET radiotracer, 3-[18 F]fluoro- para -hydroxyphenethylguanidine (3-[18 F]pHPG), a norepinephrine analogue, for its ability to localize PCC/PGL. METHODS: 3-[18 F]pHPG PET/CT whole-body scans were performed on 16 patients (8 male:8 female; mean age 47...
April 6, 2024: Journal of the Endocrine Society
https://read.qxmd.com/read/38611027/effects-of-peptide-receptor-radiotherapy-in-patients-with-advanced-paraganglioma-and-pheochromocytoma-a-nation-wide-cohort-study
#8
JOURNAL ARTICLE
Linda Skibsted Kornerup, Mikkel Andreassen, Ulrich Knigge, Anne Kirstine Arveschoug, Per Løgstup Poulsen, Andreas Kjær, Peter Sandor Oturai, Henning Grønbæk, Gitte Dam
INTRODUCTION: Pheochromocytomas and paragangliomas are rare neuroendocrine tumours that originate from chromaffin cells within the adrenal medulla or extra-adrenal sympathetic ganglia. Management of disseminated or metastatic pheochromocytomas and paragangliomas continues to pose challenges and relies on limited evidence. METHOD: In this study, we report retrospective data on median overall survival (OS) and median progression-free survival (PFS) for all Danish patients treated with peptide receptor radionuclide therapy (PRRT) with 177 Lu-Dotatate or 90 Y-Dotatate over the past 15 years...
March 29, 2024: Cancers
https://read.qxmd.com/read/38576115/molecular-imaging-in-canvas-a-contribution-for-differential-diagnosis
#9
Tatiana Horowitz, Eric Guedj, Alexandre Eusebio, Frédérique Fluchère, Jean-Philippe Azulay, Emilien Delmont, Stephan Grimaldi
BACKGROUND: Phenotypes of CANVAS are increasingly diversified, including bradykinesia and dysautonomia, so that its primary differential diagnoses are multiple system atrophy-cerebellar type (MSA-c), and spinocerebellar ataxia type 3 (SCA3). This case series aims to highlight key molecular imaging findings in CANVAS. CASES: We report a case series of six patients with CANVAS who underwent nuclear medicine examinations in our center and 13 patients from the literature...
April 4, 2024: Movement Disorders Clinical Practice
https://read.qxmd.com/read/38574255/a-rare-case-of-abnormal-diffuse-brain-uptake-on-an-123i-mibg-scan-in-a-patient-with-high-risk-neuroblastoma
#10
JOURNAL ARTICLE
Deepashri Basavalingu, Murat Sadic, Safia Cheeney, Marguerite T Parisi
123I-meta-iodobenzylguanidine (123I-MIBG) is extensively used for initial staging and response evaluation in children with neuroblastoma. Physiological uptake of 123I-MIBG occurs in the salivary glands, liver, adrenal gland, myocardium, bowel, and thyroid gland. 123I-MIBG cannot cross an intact blood-brain barrier. We present the rare case of a 3-year-old boy with neuroblastoma and meningeal metastases who underwent an 123I-MIBG scan for disease restaging that showed abnormal brain uptake. Abnormal MIBG uptake in the brain can occur if there is disruption of the blood-brain barrier either secondary to metastases or after damage to blood-brain barrier...
May 1, 2024: Clinical Nuclear Medicine
https://read.qxmd.com/read/38553298/advances-in-clinical-care-with-contemporary-cardiac-spect
#11
JOURNAL ARTICLE
Ronald G Schwartz, Jean-Pierre Iskandar, Prem Soman
State of the art of cardiac SPECT imaging continues to advance. Contemporary clinical applications of cardiac SPECT are reviewed and illustrated. Beyond traditional stress and rest myocardial perfusion imaging, the role of digital SPECT technology, ultra low dose imaging with efficient stress first / stress only if normal imaging, deep learning algorithms relative to coronary angiography and SPECT CT, sourceless emission attenuation correction, myocardial blood flow and blood flow reserve to assess ischemic jeopardy, culprit ischemic territories, and cardiac allograft vasculopathy, advanced methods of SPECT detection of amyloid cardiomyopathy, resting MPI to define pre-operative regional scar prior to operative ablation, parametric radionuclide ventriculography to quantify dyssynchrony and benefit of biventricular pacing, assessment of treatment response of RV and LV function in patients with pulmonary hypertension, dual isotope MIBG imaging to assess cardiac risk, and the value proposition of real world effectiveness of SPECT cardiac imaging are illustrated...
March 28, 2024: Journal of Medical Imaging and Radiation Sciences
https://read.qxmd.com/read/38546331/increasing-catecholamine-secretion-through-npy-in-pheochromocytomas-with-false-negative-123i-mibg-scintigraphy
#12
JOURNAL ARTICLE
Yutaro Ruike, Sawako Suzuki, Koutaro Yokote
INTRODUCTION: 123I-MIBG has been well established as a functional imaging tool, and 131I-MIBG therapy is being considered for catecholamine-secreting tumors. Tumors with the characteristics of a noradrenergic biochemical phenotype, small, malignant, metastatic, extra-adrenal, bilateral, and hereditary, especially SDHx-related tumors, are reported to correlate with reduced MIBG uptake. However, the potential molecular mechanisms influencing MIBG uptake have been poorly studied. PATIENTS AND METHODS: To identify critical genes that may enhance MIBG accumulation in pheochromocytomas (PCCs), we performed RNA-seq analyses for 16 operated patients with PCCs (6 MIBG-negative and 10 MIBG-positive) combined with RT-qPCR for 27 PCCs (5 MIBG-negative and 22 MIBG-positive) and examined primary cultures of the surgical tissues...
March 25, 2024: Clinical Nuclear Medicine
https://read.qxmd.com/read/38537216/unusual-renal-uptake-of-131i-mibg-in-a-young-hypertensive-with-renal-artery-stenosis
#13
JOURNAL ARTICLE
Agrawal Roopal, Malhotra Gaurav
A 10-year-old hypertensive girl underwent 131I-MIBG scan to rule out neural crest derived tumor. The whole-body images revealed diffuse intense tracer uptake in the right kidney, which persisted in 96-hour images as well. CT renal angiography revealed 90% to 95% right renal artery stenosis. Thereafter, she underwent baseline and angiotensin receptor blockade renal dynamic imaging, which revealed hemodynamically significant renal artery stenosis. Pattern of diffuse and intense 131I-MIBG uptake, albeit rare, still warrants further evaluation to rule out renal artery stenosis and investigate its hemodynamic significance for appropriate management...
March 25, 2024: Clinical Nuclear Medicine
https://read.qxmd.com/read/38520971/functional-vagal-paraganglioma-developing-15-years-after-resection-of-a-retroperitoneal-paraganglioma
#14
Fumiya Kojima, Kazuchika Ohno, Naoki Fushimi, Ryosuke Takahashi, Akihisa Tasaki, Takahiro Asakage
The patient, a 40-year-old woman, was diagnosed as having a functional right vagal paraganglioma (PGL) 15 years after undergoing resection for a retroperitoneal PGL. 123 I-MIBG scintigraphy showed no accumulation, but as the blood noradrenaline and urinary normetanephrine concentrations were elevated, the tumor was judged as being functional, and surgery was scheduled. The patient was started on doxazosin infusion and embolization of the tumor feeding vessel was performed before the surgery. Intraoperative examination showed that the tumor was contiguous with the vagal nerve, necessitating combined resection of the vagal nerve with the tumor...
March 22, 2024: Auris, Nasus, Larynx
https://read.qxmd.com/read/38517586/the-role-of-123-i-mibg-cardiac-scintigraphy-in-the-differential-diagnosis-between-dementia-with-lewy-bodies-and-alzheimer-s-disease
#15
REVIEW
Giacomo Monzio Compagnoni, Ildebrando Appollonio, Carlo Ferrarese
Although detailed diagnostic guidelines are available, differentiating dementia with Lewy bodies from Alzheimer's disease is often difficult. 123-I-MIBG cardiac scintigraphy is one of the tools which have been proposed for the diagnostic procedure. The present review is aimed at evaluating the available literature about this topic. Studies assessing the use of this technique to differentiate between the two diseases have been examined and reported. Overall, despite a certain study-to-study variability, the available literature suggests that 123-I-MIBG cardiac scintigraphy is an effective tool in differentiating between the two diseases, with high sensitivity and specificity values...
March 22, 2024: Neurological Sciences
https://read.qxmd.com/read/38492045/predicting-event-free-survival-after-induction-of-remission-in-high-risk-pediatric-neuroblastoma-combining-123-i-mibg-spect-ct-radiomics-and-clinical-factors
#16
JOURNAL ARTICLE
Lijuan Feng, Xu Yang, Chao Wang, Hui Zhang, Wei Wang, Jigang Yang
BACKGROUND: Accurately quantifying event-free survival after induction of remission in high-risk neuroblastoma can lead to better subsequent treatment decisions, including whether more aggressive therapy or milder treatment is needed to reduce unnecessary treatment side effects, thereby improving patient survival. OBJECTIVE: To develop and validate a 123 I-metaiodobenzylguanidine (MIBG) single-photon emission computed tomography-computed tomography (SPECT-CT)-based radiomics nomogram and evaluate its value in predicting event-free survival after induction of remission in high-risk neuroblastoma...
March 16, 2024: Pediatric Radiology
https://read.qxmd.com/read/38483956/the-prognostic-impact-of-follow-up-cardiac-mibg-imaging-on-lv-trajectory-after-acute-decompensation
#17
JOURNAL ARTICLE
Kiyomi Kayama, Takahisa Yamada, Masahiro Seo, Tetsuya Watanabe, Takashi Morita, Masato Kawasaki, Atsushi Kikuchi, Tsutomu Kawai, Jun Nakamura, Masatake Fukunami
AIMS: Cardiac metaiodobenzylguanidine (MIBG) imaging provides prognostic information in patients with heart failure. Recently, the trajectory of left ventricular ejection fraction (LVEF) has been a focus in patients with reduced LVEF admitted for acute decompensated heart failure (ADHF). We sought to investigate the prognostic value of follow-up cardiac MIBG imaging in ADHF patients with reduced LVEF in relation to LVEF trajectory. METHODS AND RESULTS: We prospectively studied 145 ADHF patients with reduced LVEF<40%...
March 14, 2024: European Heart Journal Cardiovascular Imaging
https://read.qxmd.com/read/38461108/multi-modal-3-dimensional-visualization-of-pediatric-neuroblastoma-aiding-surgical-planning-beyond-anatomical-information
#18
JOURNAL ARTICLE
Dominique C Simons, Myrthe A D Buser, Matthijs Fitski, Cornelis P van de Ven, Bernhard Ten Haken, Marc H W A Wijnen, Can Ozan Tan, Alida F W van der Steeg
BACKGROUND: Patient-specific 3D models of neuroblastoma and relevant anatomy are useful tools for surgical planning. However, these models do not represent the heterogenous biology of neuroblastoma. This heterogeneity is visualized with the ADC and 123 I-MIGB-SPECT-CT imaging. Combining these multi-modal data into preoperative 3D heatmaps, may allow differentiation of the areas of vital and non-vital tumor tissue. We developed a workflow to create multi-modal preoperative 3D models for neuroblastoma surgery...
February 24, 2024: Journal of Pediatric Surgery
https://read.qxmd.com/read/38435205/pheochromocytoma-with-high-adrenocorticotropic-hormone-production-capacity-without-pigmentation-and-cushingoid-symptoms-a-case-report-with-a-literature-review
#19
Gen Mizutani, Masashi Isshiki, Eisuke Shimizu, Daigo Saito, Akira Shimada
Pheochromocytoma or paraganglioma (PPGL) originating from chromaffin cells can produce diverse hormones in addition to catecholamines, including adrenocorticotropic hormone (ACTH). In pheochromocytoma, high levels of ACTH might not result in pigmentation as typically observed in Addison's disease, and patients might not exhibit the symptoms of Cushing's syndrome, despite ACTH-dependent hypercortisolism. A 63-year-old male patient with hypertension was admitted to our facility, and computed tomography (CT) revealed a large right adrenal tumor...
February 2024: Curēus
https://read.qxmd.com/read/38432865/value-of-nuclide-scintigraphy-in-the-diagnosis-and-prognosis-of-cardiac-amyloidosis
#20
JOURNAL ARTICLE
Qu Mo, Zilong Deng, Yi Xiao, Caiguang Liu, Min Zhao
Amyloidosis is a local or systemic disease caused by the deposition of misfolded proteins outside the cell, with rapid progression, and dire prognosis. Common types of cardiac amyloidosis are monoclonal immunoglobulin light chain amyloidosis (AL-CA) and transthyretin cardiac amyloidosis (ATTR-CA). Nuclear medicine examinations can be accurate, rapid, and non-invasive to help diagnose diseases and can effectively predict the prognosis of patients with CA. Technetium (99 Tcm )-labeled bisphosphonate imaging has been included in the consensus of experts and has become the first-line imaging method for the diagnosis of ATTR-CA...
November 28, 2023: Zhong Nan da Xue Xue Bao. Yi Xue Ban, Journal of Central South University. Medical Sciences
keyword
keyword
46966
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.